Reliability and characteristics of atrial tachyarrhythmias detection in dual chamber pacemakers

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1090-1097

  Kohno, Ritsuko ^a   Abe, Haruhiko ^a   Oginosawa, Yasushi ^a   Tamura, Masahito ^a   Takeuchi, Masaaki ^a   Nagatomo, Toshihisa ^a   Otsuji, Yutaka ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Atrial high rate detection; Atrial overdrive pacing; Atrial tachyarrhythmia; Dual chamber pacing; Repetitive non reentrant ventriculoatrial synchrony

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ALGORITHM; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACEMAKER; HEART ATRIUM PACING; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PACING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; NEOPLASM; REENTRY TACHYCARDIA; RELIABILITY; SENSITIVITY AND SPECIFICITY; SICK SINUS SYNDROME; STROKE; SUPRAVENTRICULAR TACHYCARDIA; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ALGORITHMS; CARDIAC PACING, ARTIFICIAL; HEART ATRIA; HUMANS; PACEMAKER, ARTIFICIAL; SENSITIVITY AND SPECIFICITY; TACHYCARDIA;

EID: 79955689681     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0896     Document Type: Article

References (24)

1. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett EL. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-227.
2. Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol 1998; 21: 250-255.
3. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107: 1614-1619.
4. Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Longterm risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004; 43: 47-52.
5. Orlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA. Asymptomatic atrial fibrillation in pacemaker recipients: Incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol 2007; 30: 404-411.
6. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005; 46: 1913-1920.
7. Israel CW, Hügl B, Unterberg C, Lawo T, Kennis I, Hettrick D, et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12: 1121-1128.
8. Wiberg S, Lönnerholm S, Jensen SM, Blomström P, Ringqvist I, Blomström-Lundqvist C. Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: A multicenter randomized study, the PAF-PACE study. Pacing Clin Electrophysiol 2003; 26: 1841-1848.
9. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003; 42: 627-633.
10. Blanc JJ, De Roy L, Mansourati J, Poezevara Y, Marcon JL, Schoels W, et al. Atrial pacing for prevention of atrial fibrillation: Assessment of simultaneously implemented algorithms. Europace 2004; 6: 371-379.
11. Mont L, Ruiz-Granell R, Martínez JG, Carmona JR, Fidalgo M, Cobo E, et al. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: Results of the prevention or termination (POT) trial. Europace 2008; 10: 28-34.
12. Gold MR, Adler S, Fauchier L, Haffajee C, Ip J, Kainz W, et al. Impact of atrial prevention pacing on atrial fibrillation burden: Primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 2009; 6: 295-301.
13. Lee MA, Weachter R, Pollak S, Kremers MS, Nail AM, Silverman R, et al; ATTEST Investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003; 41: 1926-1932.
14. Padeletti L, Pürerfellner H, Adler SW, Waller TJ, Harvey M, Horvitz L, et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003; 14: 1189-1195.
15. de Voogt W, van Hemel N, de Vusser P, Mairesse GH, van Mechelen R, Koistinen J, et al. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation. Europace 2007; 9: 798-804.
16. Gillis AM, Morck M, Exner DV, Sheldon RS, Duff HJ, Mitchell BL, et al. Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up. Europace 2009; 11: 1041-1047.
17. Kohno R, Abe H, Nagatomo T, Otsuji Y. Repetitive non-reentrant VA synchrony and pacemaker-mediated tachycardia induced by the AF suppression algorithm. Pacing Clin Electrophysiol 2009; 32: 1333-1335.
18. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device- Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008; 117: 350-408.
19. Dabrowska-Kugacka A, Lewicka-Nowak E, Tybura S, Wilczek R, Staniewicz J, Zagozdzon P, et al. Survival analysis in patients with preserved left ventricular function and standard indication for permanent cardiac pacing randomized to right ventricular apical or septal outflow tract pacing. Circ J 2009; 73: 1812-1819.
20. Takemoto Y, Hasebe H, Osaka T, Yokoyama E, Kushioyama Y, Suzuki T, et al. Right ventricular septal pacing preserves long-term left ventricular function via minimizing pacing-induced left ventricular dyssynchrony in patients with normal baseline QRS duration. Circ J 2009; 73: 1829-1835.
21. Hohnloser SH, Capucci A, Fain E, gold MR, van Gelder IC, Healey J, et al. Asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial (ASSERT). Am Heart J 2006; 152: 442-447.
22. Barold SS. Repetitive reentrant and non-reentrant ventriculoatrial synchrony in dual chamber pacing. Clin Cardiol 1991; 14: 754-763.
23. Barold SS. Pacemaker induced repetitive nonreentrant ventriculoatrial synchrony: Initiation and termination by ventricular extrasystole. Pacing Clin Electrophysiol 1997; 20: 989-992.
24. Barold SS, Levine PA. Pacemaker repetitive nonreentrant ventriculoatrial synchronous rhythm: A review. J Interv Card Electrophysiol 2001; 5: 45-58.